Johnson & Johnson’s filing comes a month after Medtronic gained U.S. clearance for its Hugo system as competition in the soft ...

The China-based surgical robot manufacturer is gearing up for growth after receiving Europe’s CE mark last year for its ...

Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...

The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure ...

Stanley Bergman has worked at Henry Schein for 45 years, more than 35 of which he spent as CEO, and was due to retire at the ...

Executives at companies innovating a range of new robotic surgery platforms shared their progress and challenges in MedTech ...

The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...

The chief medical officer is interested in an easier path to market for health screening features in wearable devices.

Under the agreement, the engineering partner will be responsible for a significant portion of the software development for ...

Artificial intelligence combines ultrasound and X-ray images to give physicians a real-time 3D view of the repair device during transcatheter heart procedures. Edwards’ Pascal and Abbott’s MitraClip ...

The Sapien M3 device is the first approved mitral regurgitation treatment to use a transseptal approach, Edwards said.

Editor's note: This is the first story in a two-part series on the medtech IPO landscape. You can read the second story on how to take a company public here. When Ceribell went public in October, the ...